Dr. Anne Peled, a two-time breast cancer survivor, underwent a sensation-preserving mastectomy, a procedure she co-developed.

San Francisco-based surgeon Dr. Anne Peled, herself a two-time breast cancer survivor, sat down for an interview with CURE to ...

The trauma of the initial diagnosis triggers anxiety whenever the daughter calls, reflecting the lasting impact. If you’re ...

The FDA approved Darzalex Faspro with Velcade, Revlimid and dexamethasone for newly diagnosed multiple myeloma ineligible for ...

The FDA granted breakthrough therapy designation to bezuclastinib plus Sutent for patients with gastrointestinal stromal ...

The FDA granted fast track designation to IBI3003 for patients with relapsed/refractory multiple myeloma after receiving four-plus lines of therapy.

Many childhood cancer survivors do not receive essential follow-up care, and researchers from the Keck School of Medicine of ...

A positive mindset and resilience are crucial in overcoming the challenges of a cancer diagnosis and can be cultivated ...

Low baseline ctDNA levels in advanced breast cancer patients predict better response to targeted therapy and longer ...

The FDA's breakthrough therapy designation facilitates accelerated development and regulatory review for therapies showing ...

Discover inspiring messages of hope from cancer survivors, emphasizing resilience, scientific advancements, and the ...

Explore the evolving landscape of myeloma treatment, focusing on maintenance therapies and patient experiences with ...